Wong Vivien
Insider CIK 1638050 · PGNX Executive Vice President · CYTH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CYTH Cyclo Therapeutics, Inc. | A Award | 2025-02-27 | 2025-03-03 | 25,140 | — | $0 | 64,853 | SEC↗ |
| CYTH Cyclo Therapeutics, Inc. | A Award | 2024-11-15 | 2024-11-18 | 15,145 | — | $0 | 39,713 | SEC↗ |
| CYTH Cyclo Therapeutics, Inc. | A Award | 2024-08-16 | 2024-08-20 | 7,937 | — | $0 | 24,568 | SEC↗ |
| CYTH Cyclo Therapeutics, Inc. | A Award deriv | 2024-06-03 | 2024-06-05 | 15,562 | — | $0 | 15,562 | SEC↗ |
| CYTH Cyclo Therapeutics, Inc. | A Award | 2024-06-03 | 2024-06-05 | 7,813 | — | $0 | 16,631 | SEC↗ |
| CYTH Cyclo Therapeutics, Inc. | A Award | 2024-02-13 | 2024-02-15 | 6,330 | — | $0 | 8,818 | SEC↗ |
| CYTH Cyclo Therapeutics, Inc. | A Award | 2023-11-28 | 2023-11-30 | 2,488 | — | $0 | 2,488 | SEC↗ |
| CYTH Cyclo Therapeutics, Inc. | A Award deriv | 2023-08-17 | 2023-08-21 | 6,700 | — | $0 | 6,700 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 82,214 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 90,750 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 94,875 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 82,500 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 82,500 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 66,000 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 75,000 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 52,800 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 48,000 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 6,000 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 25,000 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 40,000 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer deriv | 2020-06-19 | 2020-06-23 | 60,000 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | D To issuer | 2020-06-19 | 2020-06-23 | 4,121 | — | $0 | 0 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2020-03-02 | 2020-03-04 | 82,214 | — | $0 | 82,214 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2019-03-01 | 2019-03-05 | 90,750 | — | $0 | 90,750 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2018-03-01 | 2018-03-02 | 94,875 | — | $0 | 94,875 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2017-03-01 | 2017-03-07 | 82,500 | — | $0 | 82,500 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2016-03-01 | 2016-03-03 | 82,500 | $4.52 | $372.9K | 82,500 | SEC↗ |